TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | -4 | -1 | -13 | -7 | 11 | 22 | 2 |
| P | %wins | 50 | 50 | 0 | 50 | 50 | 50 | 42 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/7/26 13:48 | 1/5/26 | INDV | Indivior Plc | X0 | Health | Drug | Pharmaceutical Preparations | Stejbach Mark | VA | D | P | 27 | 35.39 | 0 | 1 | 5 | 17 | D | |||||||||||||||
5/27/20 16:14 | 5/26/20 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Stejbach Mark | MA | D | P | 20 | 9.75 | 0 | 2 | 130 | 4 | D | |||||||||||||||
6/20/17 16:24 | 6/16/17 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Stejbach Mark | MA | D | P | 27 | 17.02 | 0 | 2 | New | 2 | I | |||||||||||||||
11/19/12 18:36 | 11/13/12 | ALKS | Alkermes Plc. | Health | Drug | Pharmaceutical Preparations | Stejbach Mark | MA | O | Chief Co | P | 24 | 20.13 | 17 | 1 | 600 | 1 | D | 81 | 21 | 17 | 9 | -5 | 6 | -2 | -3 | 0 | 0 | -3 | 8 | 62 | 87 | |
4/13/10 16:24 | 4/9/10 | TNGN | Tengion Inc | Health | BioPrd | Biological Products, (No Diag | Stejbach Mark | PA | O | VP,Chief | P | 1 | 5.00 | 3 | 0 | New | 0 | D | -7 | -1 | -23 | -21 | -40 | -44 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |